Literature DB >> 22771100

Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study.

Tae Hoon Lee1, Jong Ho Moon, Hyun Jong Choi, Seung Hyo Han, Young Koog Cheon, Young Deok Cho, Sang-Heum Park, Sun-Joo Kim.   

Abstract

BACKGROUND: Post-ERCP pancreatitis (PEP) is the most common and serious complication of ERCP. Difficult biliary cannulation can be a procedure-related risk factor for PEP. Recent studies reported that a prophylactic pancreatic stent (PS) can reduce the frequency and severity of PEP.
OBJECTIVE: To evaluate the efficacy and usefulness of a temporary 3F PS to prevent PEP in patients with difficult biliary cannulations.
DESIGN: A multicenter, prospective, randomized study.
SETTING: Two tertiary-care academic medical centers. PATIENTS: In total, 101 patients with a difficult biliary cannulation were randomly divided into the 3F PS placement group (PS group, n = 50) or the nonstent (NS) group (NS group, n = 51).
INTERVENTIONS: Endoscopic placement of a 3F unflanged PS. MAIN OUTCOME MEASUREMENTS: The incidence and severity of PEP in the 2 groups, spontaneous dislodgment of stents, and procedure-related complications.
RESULTS: The technical success rate of 3F PS placement was 96% (48/50). The lengths of the stents were 4 cm (n = 21), 6 cm (n = 15), and 8 cm (n = 12). Spontaneous stent dislodgment within 7 days occurred in 94% of patients (45/48). The mean duration until spontaneous dislodgment was 3.5 days. The incidence rate of PEP was 12% (6/50: mild, 5; moderate, 1) in the PS group and 29.4% (15/51: mild, 12; moderate, 2; severe, 1) in the NS group. Severe pancreatitis occurred in only 1 patient in the NS group. In a multivariate analysis, prophylactic placement of PS was the only prophylactic factor for PEP (odds ratio, 0.126; 95% CI, 0.025-0.632, P = .012). LIMITATIONS: No comparative results for stent size and diameter and a low-risk cohort group.
CONCLUSIONS: Prophylactic temporary 3F PS placement in patients with a difficult biliary cannulation during ERCP seems to be a safe and effective method for reducing PEP and results in a high rate of spontaneous passage of stents without complications.
Copyright © 2012 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22771100     DOI: 10.1016/j.gie.2012.05.001

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  17 in total

1.  Impact of pancreatic stent caliber on post-endoscopic retrograde cholangiopancreatogram pancreatitis rates in patients with confirmed sphincter of Oddi dysfunction.

Authors:  Jayapal Ramesh; Hwasoon Kim; Kartika Reddy; Shyam Varadarajulu; C Mel Wilcox
Journal:  J Gastroenterol Hepatol       Date:  2014       Impact factor: 4.029

Review 2.  Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Jin-He Fan; Jun-Bo Qian; Ya-Min Wang; Rui-Hua Shi; Cheng-Jin Zhao
Journal:  World J Gastroenterol       Date:  2015-06-28       Impact factor: 5.742

Review 3.  Endoscopic prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Tae Hoon Lee; Do Hyun Park
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

4.  Needle-knife fistulotomy vs double-guidewire technique in patients with repetitive unintentional pancreatic cannulations.

Authors:  Su Jin Kim; Dae Hwan Kang; Hyung Wook Kim; Cheol Woong Choi; Su Bum Park; Byeong Jun Song; Young Mi Hong
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 5.  Prophylactic pancreatic stent placement and post-ERCP pancreatitis: an updated meta-analysis.

Authors:  Takero Mazaki; Kazunari Mado; Hideki Masuda; Motomi Shiono
Journal:  J Gastroenterol       Date:  2013-04-24       Impact factor: 7.527

Review 6.  Prevention of post-ERCP pancreatitis.

Authors:  Jennifer Maranki; Paul Yeaton
Journal:  Curr Gastroenterol Rep       Date:  2013-11

Review 7.  Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis.

Authors:  Qing-Qing Shi; Xiao-Yi Ning; Ling-Ling Zhan; Guo-Du Tang; Xiao-Ping Lv
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

8.  Preventing Post-ERCP Pancreatitis: The Role of Prophylactic Pancreatic Duct Stenting in the Rectal NSAID Era.

Authors:  Noor-L-Houda Bekkali; Tom Thomas; Margaret Geraldine Keane; Sam Murray; Deepak Joshi; Ghassan Elsayed; Gavin James Johnson; Michael Huw Chapman; Stephen Paul Pereira; George John Mitchell Webster
Journal:  JOP       Date:  2017-07-31

9.  The feasibility of pancreatic duct stenting using a novel 4-Fr plastic stent with a 0.025-in. guidewire.

Authors:  Kazumasa Nagai; Atsushi Sofuni; Takayoshi Tsuchiya; Kentaro Ishii; Reina Tanaka; Ryosuke Tonozuka; Shuntaro Mukai; Kenjiro Yamamoto; Yukitoshi Matsunami; Yasutsugu Asai; Takashi Kurosawa; Hiroyuki Kojima; Hirohito Minami; Toshihiro Honma; Akio Katanuma; Takao Itoi
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

Review 10.  Prevention of postendoscopic retrograde cholangiopancreatography pancreatitis: the endoscopic technique.

Authors:  Byeong Jun Song; Dae Hwan Kang
Journal:  Clin Endosc       Date:  2014-05-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.